Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B and flucytosine in HIV-associated cryptococcal meningitis
NCT04140461Phase 3Unknown
- Start
- Jan 2020
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amphotericin b in cryptococcal meningitis (2 arms). Primary endpoint: Number of subjects died at weeks 48. Status: unknown.
02
Drugs
amphotericin b
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT04140461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140461.